Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

por Brocklebank, Vicky, Kavanagh, David
Publicado en Clin Kidney J (2017)

Thrombotic Microangiopathy and the Kidney

por Brocklebank, Vicky, Wood, Katrina M., Kavanagh, David
Publicado en Clin J Am Soc Nephrol (2018)

Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri

por Brocklebank, Vicky, Wong, Edwin K.S., Fielding, Rick, Goodship, Timothy H.J., Kavanagh, David
Publicado 2014

Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential

por Dowen, Frances, Wood, Katrina, Brown, Alison L., Palfrey, Jennifer, Kavanagh, David, Brocklebank, Vicky
Publicado en Clin Kidney J (2017)

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report

por Sevinc, Mustafa, Basturk, Taner, Sahutoglu, Tuncay, Sakaci, Tamer, Koc, Yener, Ahbap, Elbis, Akgol, Cuneyt, Kara, Ekrem, Brocklebank, Vicky, Goodship, Tim HJ, Kavanagh, David, Unsal, Abdulkadir
Publicado en J Med Case Rep (2015)

Hemolytic Uremic Syndrome in Pregnancy and Postpartum

por Bruel, Alexandra, Kavanagh, David, Noris, Marina, Delmas, Yahsou, Wong, Edwin K.S., Bresin, Elena, Provôt, François, Brocklebank, Vicky, Mele, Caterina, Remuzzi, Giuseppe, Loirat, Chantal, Frémeaux-Bacchi, Véronique, Fakhouri, Fadi
Publicado en Clin J Am Soc Nephrol (2017)

Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD

por Wong, Edwin K. S., Hallam, Thomas M., Brocklebank, Vicky, Walsh, Patrick R., Smith-Jackson, Kate, Shuttleworth, Victoria G., Cox, Thomas E., Anderson, Holly E., Barlow, Paul Nigel, Marchbank, Kevin James, Harris, Claire L., Kavanagh, David
Publicado en Front Immunol (2021)

A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrom...

por Challis, Rachel C., Araujo, Geisilaine S.R., Wong, Edwin K.S., Anderson, Holly E., Awan, Atif, Dorman, Anthony M., Waldron, Mary, Wilson, Valerie, Brocklebank, Vicky, Strain, Lisa, Morgan, B. Paul, Harris, Claire L., Marchbank, Kevin J., Goodship, Timothy H.J., Kavanagh, David
Publicado en J Am Soc Nephrol (2016)

Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease

por Challis, Rachel C., Ring, Troels, Xu, Yaobo, Wong, Edwin K.S., Flossmann, Oliver, Roberts, Ian S.D., Ahmed, Saeed, Wetherall, Michael, Salkus, Giedrius, Brocklebank, Vicky, Fester, Julian, Strain, Lisa, Wilson, Valerie, Wood, Katrina M., Marchbank, Kevin J., Santibanez-Koref, Mauro, Goodship, Timothy H.J., Kavanagh, David
Publicado en J Am Soc Nephrol (2017)

Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland

por Brocklebank, Vicky, Johnson, Sally, Sheerin, Thomas P., Marks, Stephen D., Gilbert, Rodney D., Tyerman, Kay, Kinoshita, Meredith, Awan, Atif, Kaur, Amrit, Webb, Nicholas, Hegde, Shivaram, Finlay, Eric, Fitzpatrick, Maggie, Walsh, Patrick R., Wong, Edwin K.S., Booth, Caroline, Kerecuk, Larissa, Salama, Alan D., Almond, Mike, Inward, Carol, Goodship, Timothy H., Sheerin, Neil S., Marchbank, Kevin J., Kavanagh, David
Publicado en Kidney Int (2017)

Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy

por Brocklebank, Vicky, Kumar, Gurinder, Howie, Alexander J., Chandar, Jayanthi, Milford, David V., Craze, Janet, Evans, Jonathan, Finlay, Eric, Freundlich, Michael, Gale, Daniel P., Inward, Carol, Mraz, Martin, Jones, Caroline, Wong, William, Marks, Stephen D., Connolly, John, Corner, Bronte M., Smith-Jackson, Kate, Walsh, Patrick R., Marchbank, Kevin J., Harris, Claire L., Wilson, Valerie, Wong, Edwin K.S., Malina, Michal, Johnson, Sally, Sheerin, Neil S., Kavanagh, David
Publicado en Kidney Int (2020)

Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2

por Duncan, Christopher J.A., Thompson, Benjamin, Chen, Rui, Rice, Gillian I., Gothe, Florian, Young, Dan F., Lovell, Simon C., Shuttleworth, Victoria G., Brocklebank, Vicky, Corner, Bronte, Skelton, Andrew J., Bondet, Vincent, Coxhead, Jonathan, Duffy, Darragh, Fourrage, Cecile, Livingston, John H., Pavaine, Julija, Cheesman, Edmund, Bitetti, Stephania, Grainger, Angela, Acres, Meghan, Innes, Barbara A., Mikulasova, Aneta, Sun, Ruyue, Hussain, Rafiqul, Wright, Ronnie, Wynn, Robert, Zarhrate, Mohammed, Zeef, Leo A.H., Wood, Katrina, Hughes, Stephen M., Harris, Claire L., Engelhardt, Karin R., Crow, Yanick J., Randall, Richard E., Kavanagh, David, Hambleton, Sophie, Briggs, Tracy A.
Publicado en Sci Immunol (2019)